Aytu BioScience, Inc. (AYTU)
Commercial Portfolio Acquisition Overview Conference Call
October 14, 2019 4:30 P.M. ET
Company Participants
Josh Disbrow - Chairman and Chief Executive Officer
Conference Call Participants
Jeffrey Cohen - Ladenburg Thalmann
Carl Byrnes - Northland Capital Markets
Presentation
Operator
Good afternoon, everyone, and thank you for joining us for this Conference Call discussing Aytu BioScience’s Announced Acquisition of a Six Product Commercial Portfolio. With me this afternoon to discuss the details of the acquisitions is Aytu’s Chairman and Chief Executive Officer, Josh Disbrow.
Aytu BioSciences issued a press release this morning announcing